Thompson Davis & Co’s Apyx Medical APYX Stock Holding History

Thompson Davis & Co’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$240K	Buy	33,789 +33,289	+6,658%	+$185K	0.52%	49
2018 Q2	$2K	Buy	+500	New	+$1.84K	﹤0.01%	600
2017 Q2	–	Sell	-1,000	Closed	-$3K	–	1071
2017 Q1	$3K	Sell	1,000 -1,000	-50%	-$3.32K	﹤0.01%	978
2016 Q4	$7K	Sell	2,000 -5,500	-73%	-$24.5K	0.01%	774
2016 Q3	$39K	Buy	+7,500	New	+$24.3K	0.07%	289
2014 Q3	–	Sell	-4,000	Closed	-$15K	–	1135
2014 Q2	$15K	Buy	4,000 +1,000	+33%	+$4.04K	0.02%	429
2014 Q1	$12K	Sell	3,000 -1,500	-33%	-$4.42K	0.02%	459
2013 Q4	$10K	Buy	+4,500	New	+$11K	0.02%	447

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Thompson Davis & Co's APYX Position: Q3 2018 in Review

Thompson Davis & Co increased its Apyx Medical (APYX) stake by 6,658% in Q3 2018, buying an estimated $185K and bringing the position to 33,789 shares worth $240K. The position accounts for 0.52% of the portfolio, ranked #49.

Thompson Davis & Co first reported a position in APYX in Q4 2013 and has held it in 8 quarters since. 56 funds tracked by Wall St. Rank hold APYX as of Q3 2018.

Thompson Davis & Co held 33,789 shares of Apyx Medical worth $240K as of Q3 2018.
Thompson Davis & Co bought 33,289 Apyx Medical shares in Q3 2018, an estimated $185K.
Apyx Medical made up 0.52% of Thompson Davis & Co's portfolio in Q3 2018, its #49 holding.
Thompson Davis & Co first reported a position in Apyx Medical in Q4 2013 and has held it in 8 quarters since.
56 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.